Can a simple infusion keep blood pressure stable during surgery?
NCT ID NCT06885268
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether giving a medicine called noradrenaline through a vein during surgery can prevent dangerous drops in blood pressure better than usual care. About 750 adults aged 45 and older having non-cardiac surgery will take part. The goal is to see if this approach reduces episodes of very low blood pressure and related heart problems.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 3
Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.
- Participants
-
About 750 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jun 2025
- Expected to finish
-
Jun 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
45 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. ≥45 years old 2. Elective or accelerated\* non-cardiac surgery expected to last ≥1 hour and requiring general, neuraxial, or combined general with neuraxial anesthesia 3. Expected to stay overnight in the hospital after surgery 4. Written informed consent to participate in the HYP-NOR Trial provided 5. American Society of Anesthesiologists (ASA) physical status class II or higher. Exclusion Criteria: 1. Newly diagnosed, untreated, or uncontrolled hypertension -in two measurements on the day before surgery Systolic Blood Pressure (SBP) ≥180 mm Hg or Diastolic Blood Pressure (DBP) ≥110 mm Hg 2. Persistent difference in recorded SBP between right and left upper limb \>10 mm Hg 3. Persistent atrial fibrillation 4. Have a documented history of dementia 5. Have language, vision, or hearing impairments that may compromise cognitive assessments 6. Have a condition that precludes routine blood pressure management such as surgeon request for relative hypotension 7. Receiving irreversible nonselective monoamine oxidase inhibitors (e.g. tranylcypromine, phenelzine) within 2 weeks preceding study enrolment 8. The use of tricyclic antidepressants 9. Have Prinzmetal angina 10. Have contraindications to noradrenaline per clinician judgement 11. Noradrenaline infusion started before surgery or plan to use continuous noradrenaline infusion throughout the procedure 12. Treating physician (surgeon/anaesthetist) decides on the necessity of extended continuous hemodynamic monitoring during or after surgery 13. Severe kidney disease (MDRD creatinine clearance \<15 mL/min/1.73m2) or renal replacement therapy 14. End-stage heart failure: defined as NYHA Class IV - severe limitations in daily activity. Patients experience symptoms even while at rest. Mostly bedbound patients. 15. Known severe liver disease: defined as the presence of liver cirrhosis or any of the symptoms of severe liver dysfunction: portal hypertension (esophageal varices, ascites), hepatocellular insufficiency (e.g., jaundice, hepatic encephalopathy) and coagulopathy (prolonged INR/APTT associated with known liver dysfunction). 16. Emergency and urgent surgery defined as performed within 24 hours of sudden illness/unplanned admission to hospital 17. Have previously participated in the trial: patient already took a part in the HYP-NOR trial in the past 18. Pregnant or breastfeeding women.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Blood pressure management are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
4 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
5 Wojskowy Szpital Kliniczny z Polikliniką Samodzielny Publiczny Zakład Opieki Zdrowotnej w Krakowie
RECRUITINGKrakow, 30-901, Poland
-
Samodzielny Publiczny Szpital Kliniczny Nr 1 im. Prof. Stanisława Szyszko Śląskiego Uniwersytetu Medycznego w Katowicach
RECRUITINGZabrze, 41-800, Poland
-
Uniwersytecki Szpital Kliniczny w Opolu
RECRUITINGOpole, 45-401, Poland
-
Uniwersyteckie Centrum Kliniczne im. Prof. Kornela Gibińskiego Śląski Uniwersytet Medyczny
RECRUITINGKatowice, 40-752, Poland
-
Wojewódzki Szpital Specjalistyczny w Olsztynie
ACTIVE_NOT_RECRUITINGOlsztyn, 10-561, Poland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can AI predict dangerous blood pressure drops during lung surgery?
- Which anesthetic keeps blood pressure steadier during aortic surgery?
- Can a new anesthetic protect older Patients' blood pressure during surgery?
- Which blood pressure drug protects organs better during spine surgery?
- Ultrasound tailors anesthesia dose to spinal canal size, aiming to prevent dangerous blood pressure dips
- A new anesthesia drug may keep blood pressure steadier during liver surgery